DH (definitivehc.com) Business Value to Revenue

Public company logo of Definitive Healthcare Corp. (DH)

High costs associated with aggregating unique medical databases create significant barriers to entry for competitors. The EV/Sales chart serves as an indicator of market resilience, where 932.95 describes the current status of the metric. Stable ARR and demand from pharma behemoths for AI-driven Big Data neutralize risks, while the cloud subscription model mitigates dependence on biotech sector IT budgets for Definitive Healthcare (DH).

Definitive Healthcare Corp. - DH EV/Sales Multiple (period 11/23/2025 - 11/19/2026)

DH (Definitive Healthcare Inc.): analytical breakdowns and indicator data

- business market valuation indicators:
Fundamental valuation:Definitive Healthcare (DH)
Mass-produced product of Definitive Healthcare Corp

Reduced analytics budgets among pharmaceutical clients directly limit the expansion of Definitive Healthcare. Under these conditions, the enterprise value-to-sales multiple on GURU.Markets values the business by excluding the impact of leverage. This metric compares market capitalization with operating revenue to identify asset overvaluation. This chart reflects market sensitivity to the churn of small-scale users. The current trend captures the investor consensus regarding the pace of the platform's technological updates.

Competitor analysis for Definitive Healthcare

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|OMCL - Company Value to Revenue|GDRX - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Schrodinger Corp SDGR|PHR: EV/Sales Multiple|OMDA - Total Company Value-to-Revenue Ratio|EVH (Evolent Health Inc) - EV/Sales Multiple|Company Value to Revenue Ratio HSTM (HealthStream)|Company Value to Revenue CCSI (Consensus)|Total Company Value-to-Revenue Ratio Agilon Health|EV/Sales Multiple ABSI (Absci)|soyoung.com (SY) - Enterprise Value-to-Revenue Multiple|NRC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)